Cancer Research

Chromogranin A could be marker for primary liver cancers

Published in Cancer Weekly, December 24th, 2002

by Sonia Nichols, senior medical writer - A marker commonly associated with neuroendocrine tumors could also be a useful prognostic indicator for hepatocellular carcinoma (HCC).

According to N. Leone and coworkers at Molinette Hospital in Turin, Italy, serum chromogranin A levels rise in patients with epithelioid tumors that differentiate. High levels of the marker predict worse outcomes. The investigators now believe chromogranin A levels also rise in patients with HCC, signaling neuroendocrine differentiation in those tumors as well.

Leone and colleagues analyzed chromogranin A levels in 79 patients with diagnoses of HCC and cirrhosis.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-12-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry